Please assess the completion status of the following clinical trial:

Trial Title: Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* All IBD and rheumatologic patients aged 18 years or older~Exclusion Criteria:~* Lack of consent~* Patients with evidence of other chronic liver disease,metabolic syndrome, men consuming more than 30 g of alcohol per day and women consuming more than 20 g of alcohol per day, patients with liver decompensation, HCC, previous liver surgery or liver transplantation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- HBV DNA level monitoring (Type: OTHER): Group with HBV DNV level being monitored regularly

Based on this trial design, predict the completion outcome and termination type (if applicable).